DEM BioPharma
PrivateLast Round
Series A
Jun 23, 2022
Total Funding Raised
$70M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
DEM BioPharma is a biotechnology company that develops innovative immunotherapeutics targeting novel signals on cancer cells and macrophages to eliminate solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DEM BioPharma Comparables
Compare DEM BioPharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pheast Therapeutics | 87% | |
| ALX Oncology | 75% | |
| ImmuneOncia Therapeutics | 74% | |
DEM BioPharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 23, 2022 |
DEM BioPharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dean Capital Investments Management | Series A |
| Alexandria Venture Investments | Series A |
| Emerson Collective | Series A |
| Astellas Venture Management | Series A |
| Pfizer Ventures | Series A |
| Pfizer | Series A |
| Longwood Fund | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 352% MoM.
- Jan 6, 2026
Presenting product DEM301 at the 2026 ASCO Gastrointestinal Cancers Symposium.
DEM BioPharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about DEM BioPharma's valuation, stock price, and market status.